CAS 192880-96-9

Formula: C7H4N2O4S2

InChI: InChI=1S/C7H4N2O4S2/c1-3-4(9(11)12)2-5(14-3)6-8-15-7(10)13-6/h2H,1H3

InChI key: ILBBOKHACYTXRK-UHFFFAOYSA-N

SMILES: CC1=C(C=C(S1)C2=NSC(=O)O2)[N+](=O)[O-]

5-(5-Methyl-4-nitrothiophen-2-yl)-1,3,4-oxathiazol-2-one

CAS: 192880-96-9

5-(5-Methyl-4-nitrothiophen-2-yl)-1,3,4-oxathiazol-2-one

Formula: C₇H₄N₂O₄S₂

Purity: 98%

Molecular weight: 244.25

Ref: 54-OR1060749

HT1171

CAS: 192880-96-9

Formula: C₇H₄N₂O₄S₂

Molecular weight: 244.25

Ref: 7W-GK4059

HT1171

CAS: 192880-96-9

5-(5-Methyl-4-nitrothiophen-2-yl)-1,3,4-oxathiazol-2-one

Formula: C₇H₄N₂O₄S₂

Purity: 98%

Molecular weight: 244.25

Ref: IN-DG01201499

HT1171

CAS: 192880-96-9

HT1171 is a potent and selective inhibitor of the Mycobacterium tuberculosis proteasome. It exhibits strong antitubercular activity against Mycobacterium tuberculosis H37Rv, with a MIC90 of 2 μg/mL and MIC of 4 μg/mL. At a concentration of 100 μM, HT1171 shows an inhibition rate of 53.8% against normal human liver cells (L02). HT1171 is applicable in antituberculosis drug research.

Formula: C₇H₄N₂O₄S₂

Color and Shape: Solid

Molecular weight: 244.248

Ref: TM-T204697

HT1171

CAS: 192880-96-9

HT1171 is an antiviral agent that is used to treat sensorineural hearing loss. It has been shown to modulate the function of the tyrosine kinase in human liver cells. HT1171 has also been shown to be active against tuberculosis and other infectious diseases, including cancer. The safety profile of this drug was evaluated by a dilution method in human liver cells and no significant toxic effects were found.

Formula: C₇H₄N₂O₄S₂

Purity: Min. 95%

Molecular weight: 244.3 g/mol

Ref: 3D-SHA88096